Type 4 gastric carcinoids are sporadic in nature, gastrin-independent, poorly differentiated neuroendocrine tumors, comprise 6–8% of all gastric carcinoids, and metastasize in 50–100% [58,59,60]. This evidence concerns the gene GAST and neuroendocrine neoplasm.